Trial NCT06050954

View at ClinicalTrials.gov 
Org. Study IDs: 23-1026

Last trial update was posted on 2023-11-09

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Metastatic Urothelial Carcinoma

Stopping Reasons

Change in standard of care.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID